Bristol Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.

Billing and
Diagnosis Codes

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Reimbursement and Coding Guide for SPRYCEL
Download


Filter by keyword Clear Filter
Type a keyword to find a specific NDC or ICD-10 code
National Drug Codes (NDC)1Issued by the FDA
0003-0527-11

COPY

20 mg, 60 tablets per bottle

0003-0528-11

COPY

50 mg, 60 tablets per bottle

0003-0524-11

COPY

70 mg, 60 tablets per bottle

0003-0855-22

COPY

80 mg, 30 tablets per bottle

0003-0852-22

COPY

100 mg, 30 tablets per bottle

0003-0857-22

COPY

140 mg, 30 tablets per bottle

International Classification of Diseases, Tenth Revision, Clinical Modification Diagnosis Codes (ICD-10-CM)2

Adult and Pediatric Chronic Myeloid Leukemia
C92

COPY

Myeloid leukemia

C92.1

COPY

Chronic myeloid leukemia (CML), BCR/ABL-positive

C92.10

COPY

Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission

C92.11

COPY

Chronic myeloid leukemia, BCR/ABL-positive, in remission

C92.12

COPY

Chronic myeloid leukemia, BCR/ABL-positive, in relapse

Adult Acute Lymphoblastic Leukemia
C91

COPY

Lymphoid leukemia

C91.0

COPY

Acute lymphoblastic leukemia (ALL)

C91.00

COPY

Acute lymphoblastic leukemia, not having achieved remission

C91.01

COPY

Acute lymphoblastic leukemia, in remission

C91.02

COPY

Acute lymphoblastic leukemia, in relapse

Pediatric Acute Lymphoblastic Leukemia
C91

COPY

Lymphoid leukemia

C91.0

COPY

Acute lymphoblastic leukemia (ALL)

C91.00

COPY

Acute lymphoblastic leukemia, not having achieved remission

C91.01

COPY

Acute lymphoblastic leukemia, in remission

*Healthcare providers should code healthcare claims based upon the service that is rendered, the patient’s medical record, the coding requirements of each health insurer, and best coding practices. Coding guidance provided under this heading does not provide a guarantee of reimbursement and should be considered together with all applicable coding guidance and standards.

References:

  1. SPRYCEL [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
  2. American Medical Association. 2020 ICD-10-CM: The Complete Official Codebook. Chicago, IL: American Medical Association; 2019.

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Support Center icon
Support Center: 1-800-861-0048
am to 8 pm ET, Mon - Fri
Schedule a Call icon rtArrY
Schedule a call from a Care CoordinatorSchedule a Call >
Request a Visit icon
Request a visit from a BMS Access & Reimbursement ManagerRequest a Visit >
Schedule a Call > Request a Visit >
BMS Logo

©2020 Bristol-Myers Squibb Company. All rights reserved. Access Support is a registered trademark of Bristol-Myers Squibb Company.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 08/20.

729US2001667-01-01 08/20